Literature DB >> 6283419

Muscle phosphoglycerate mutase deficiency.

S DiMauro, A F Miranda, M Olarte, R Friedman, A P Hays.   

Abstract

A 52-year-old man complained since adolescence of cramps and pigmenturia after 15 to 30 minutes of intense exercise. There was no family history of neuromuscular diseases, and strength was normal. The rise of venous lactate after forearm ischemic exercise was abnormally low. Histochemical and ultrastructural studies of a muscle biopsy showed mild increase of glycogen, which was confirmed by biochemical analysis. Studies of anaerobic glycolysis in vitro showed decrease lactate formation with glycogen and with all hexosephosphate glycolytic intermediates, suggesting a defect below the phosphofructokinase reaction. Muscle phosphoglycerate mutase (PGAM) activity was 5.7% of the lowest control, while all other enzymes of glycolysis had normal activities. Electrophoretic, heat lability, and mercury inhibition studies showed that the small residual activity of PGAM in the patient's muscle was represented by the brain (BB) isoenzyme, suggesting a genetic defect of the M subunit that predominates in normal muscle. The prevalence of the BB isoenzyme in other tissues, including muscle culture, may explain why symptoms were confined to muscle.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6283419     DOI: 10.1212/wnl.32.6.584

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

1.  Type 2a fibre rhabdomyolysis in myoadenylate deaminase deficiency.

Authors:  C Zimmer; H Altenkirch; S Dorfmüller-Küchlin; D Pongratz; I Paetzke; G Gosztonyi
Journal:  J Neurol       Date:  1991-02       Impact factor: 4.849

Review 2.  Muscle glycogenoses: an overview.

Authors:  S Di Mauro
Journal:  Acta Myol       Date:  2007-07

3.  Glycolysis supports embryonic muscle growth by promoting myoblast fusion.

Authors:  Vanessa Tixier; Laetitia Bataillé; Christelle Etard; Teresa Jagla; Meltem Weger; Jean Philippe Daponte; Uwe Strähle; Thomas Dickmeis; Krzysztof Jagla
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

4.  Ryanodine receptor gene point mutation and malignant hyperthermia susceptibility.

Authors:  I Moroni; E F Gonano; G P Comi; V Tegazzin; A Prelle; A Bordoni; N Bresolin; G Scarlato
Journal:  J Neurol       Date:  1995-02       Impact factor: 4.849

5.  [Diagnostic significance of muscle biopsies in metabolic myopathies. II. Clinical biochemistry].

Authors:  T Deufel; I Paetzke; D Pongratz; G Hübner; O H Wieland
Journal:  Klin Wochenschr       Date:  1984-07-16

6.  In situ mapping of the muscle-specific form of phosphoglycerate mutase gene to human chromosome 7p12-7p13.

Authors:  J Castella-Escola; M G Mattei; D M Ojcius; E Passage; C Valentin; M Cohen-Solal
Journal:  Hum Genet       Date:  1990-01       Impact factor: 4.132

7.  Clinical and biochemical evidence of skeletal muscle involvement in galactose-1-phosphate uridyl transferase deficiency.

Authors:  N Bresolin; G P Comi; F Fortunato; G Meola; A Gallanti; A Tajana; M Velicogna; E F Gonano; P Ninfali; S Pifferi
Journal:  J Neurol       Date:  1993-05       Impact factor: 4.849

Review 8.  Hereditary human myopathies in muscle culture.

Authors:  G Meola
Journal:  Ital J Neurol Sci       Date:  1991-06

9.  The molecular genetic basis of muscle phosphoglycerate mutase (PGAM) deficiency.

Authors:  S Tsujino; S Shanske; S Sakoda; G Fenichel; S DiMauro
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

10.  Muscle glucose-6-phosphate dehydrogenase deficiency.

Authors:  N Bresolin; L Bet; M Moggio; G Meola; F Fortunato; G Comi; L Adobbati; L Geremia; S Pittalis; G Scarlato
Journal:  J Neurol       Date:  1989-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.